Myriad Genetics (MYGN) Change in Inventory (2011 - 2026)

Myriad Genetics has disclosed Change in Inventory across 16 years of filings, most recently posting -$2.7 million for Q1 2026.

• In Q1 2026, Change in Inventory fell 400.0% year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at -$400000.0 (down 107.55% YoY), while the FY2025 annual figure was $3.2 million, down 48.39% from the prior year.
• Change in Inventory slipped to -$2.7 million in Q1 2026, from -$900000.0 in the prior quarter.
• Over the last five years, Change in Inventory for MYGN reached as high as $4.3 million in Q3 2022 and fell as low as -$3.2 million in Q4 2023.
• The 5-year median for Change in Inventory is $750000.0 (2023), against an average of $712500.0.
• Annual changes were most pronounced in 2023 — Change in Inventory jumped 750.0% — and 2026, when it plunged 400.0%.
• A 5-year view of Change in Inventory shows it stood at -$1.5 million in 2022, then slumped by 113.33% to -$3.2 million in 2023, then soared by 140.62% to $1.3 million in 2024, then sank by 169.23% to -$900000.0 in 2025, then tumbled by 200.0% to -$2.7 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$2.7 million, -$900000.0, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.